Analyst Upgrades: Tesla Motors Inc, Mobileye NV, and Cyberark Software Ltd

Analysts upwardly revised their ratings and price targets on Tesla Motors Inc (NASDAQ:TSLA), Mobileye NV (NYSE:MBLY), and Cyberark Software Ltd (NASDAQ:CYBR)

by Karee Venema

Published on Jul 5, 2016 at 9:20 AM

Analysts are weighing in on electric car concern Tesla Motors Inc (NASDAQ:TSLA), tech stock Mobileye NV (NYSE:MBLY), and cybersecurity firm Cyberark Software Ltd (NASDAQ:CYBR). Here's a quick roundup of today's bullish brokerage notes on TSLA, MBLY, and CYBR.

  • TSLA shrugged off reports of an investigation into a fatal accident involving its Model S sedan Friday to finish 2% higher at $216.50. However, the shares are down 3.3% ahead of the bell, as Tesla Motors Inc's lower-than-expected second-quarter delivery numbers appear to be sparking concern among speculators. Nevertheless, Baird reiterated its "outperform" rating and $338 price target -- in never-before-seen territory. Most analysts remain skeptical toward TSLA, though, with 75% maintaining a "hold" or worse suggestion.

  • Baird also chimed in on MBLY, boosting its price target to $55 from $50, while RBC Capital also raised its price target to $53 from $47. This follows last week's well-received news of a big blue-chip partnership, which helped send shares of MBLY to a year-to-date high of $49. While MBLY eventually settled the week at $47.11 -- up 11.4% on the year -- the stock is down 0.9% in electronic trading, amid broad-market headwinds. Short sellers are likely keeping a close eye on this price action. Short interest jumped 14.3% during the last two reporting periods, and now accounts for roughly one-quarter of Mobileye NV's available float.

  • CYBR is 2.6% higher ahead of the bell, after Barclays upgraded the stock's rating to "overweight" from "equal weight" and raised its price target to $60 from $44. Additionally, Cyberark Software Ltd unveiled changes to its board of directors. The shares have been rallying off their mid-February annual low of $31.50, up 53.6% as of last Friday's close at $48.37. More upside could be on the horizon, too, should short sellers capitulate to CYBR's positive price action. A healthy 7.3% of the stock's float is sold short, or nearly three times the equity's average daily trading volume.
Sign up now for Schaeffer's Opening View newsletter to get a head start on all the major pre-market news!

A Schaeffer's exclusive

6 Sectors for Summer

Access your FREE insider report before it's too late!


  
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


The Next Big Player in U.S. MJ Boom
Most pure-play marijuana stocks in the U.S. trade on the Over-the-Counter stock exchange.
Wall Street Roars Higher Amid Civil Unrest
Investors weighed a mixed bag of jobs data
AstraZeneca Stock Flat Despite COVID-19 Vaccine News
AstraZeneca saw a rise in capacity for its COVID-19 vaccine candidate
The Next Big Player in U.S. MJ Boom
Most pure-play marijuana stocks in the U.S. trade on the Over-the-Counter stock exchange.